M. Caglar et al., The utility of Tc-99m-DMSA and Tc-99m-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity, NUCL MED C, 22(12), 2001, pp. 1325-1332
A serious undesired effect of certain cytostatics is their nephrotoxicity.
In this study, we investigated the toxic effects of ifosfamide and cisplati
n by clinical and biochemical parameters in relation to Tc-99m-dimercaptosu
ccinic acid (Tc-99m-DMSA) and (TcN)-N-99m, N-ethylenedicysteine (EC) renal
scintigraphy. The indicators were urinary beta (2)-microglobulin levels, tu
bular resorption of phosphate, urinary protein and glucose excretion, glome
rular filtration rate, urinary pH and osmolarity. Thirteen paediatric patie
nts (seven boys and six girls), aged 2-16 years, were investigated. Five pa
tients received only cisplatin, six patients were treated with ifosfamide a
nd cisplatin and two with ifosfamide and carboplatin for various malignanci
es. All except three patients had normal DMSA uptake (median, 19; range, 16
-29%) prior to chemotherapy. The reduction in DMSA uptake was unilateral du
e to tumour invasion in those three patients. Following chemotherapy, DMSA
uptake showed reduction in five patients with or without clinical nephrotox
icity. The observed pattern was decreased renal uptake and elevated bladder
activity. Three patients with decreased DMSA uptake had normal tubular max
imum phosphate reabsorpsion, which suggested subclinical injury. Decrease i
n DMSA uptake and tubular phosphate reabsorption (-ITR) was detected simult
aneously in two patients. No abnormalities were seen on Tc-99m-EC scintigra
phy to suggest nephrotoxicity in our investigation. However, Tc-99m-EC clea
rly demonstrated a reduction in split renal function in children with tumou
r invasion. In summary, we found that ifosfamide induced tubular injury can
be detected with Tc-99m-DMSA scintigraphy before chemotherapy associated n
ephrotoxicity is observed by laboratory measurements. Our results also impl
y that, although a tubular agent, renal scintigraphy performed with Tc-99m-
EC is not able to detect subclinical injury or predict the outcome during t
reatment. ((C) 2001 Lippincott Williams & Wilkins).